Mark Charest

Great Point seeks to achieve positive excess returns by investing in publicly traded biotechnology, pharmaceutical and life science companies. The firm focuses on creating a balanced portfolio comprised primarily of companies that are undervalued by the public markets. Their hedge funds employ a bottom-up research-driven approach to investing in the securities of undervalued, publicly-traded healthcare companies. Great Point Partners targets fast-growing, technology- driven small-cap companies. In addition, the firm manages private equity funds that invest in private, primarily profitable, lower middle-market, growing healthcare companies.

Develops biopharmaceutical products for novel therapeutic proteins and antibodies

Functions as a College/University

Tekla primarily focuses on healthcare investing. Their funds invest in public and private growth equities in the healthcare and life sciences industries.

Operates as a management consulting and technology firm

Functions as a College/University

New Leaf Ventures invests in public and private healthcare technology companies located in the US. The firm participates in early and later-stage capital requirements.

Panorama Capital invests in companies located in the United states. The firm targets companies operating in the fields of life sciences, internet infrastructure & services and semiconductors. It provides financing for seed, early and later stage capital requirements with an investment size ranging from USD 5 - 20 million.

Conducts biomedical researches